Close Menu

And Now a Lawsuit

The Economist takes a look at the Anil Potti misconduct case at Duke University — Potti, Joseph Nevins, and colleagues published reports saying that they could predict lung cancer progression based on gene expression levels determined using microarrays. Questions began to arise about the science as well as about some claims Potti made on various documents. This led to a number of papers being retracted, clinical trials being halted, and investigations being started. Potti resigned from his position at Duke.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.